Bleomycin and IL-1beta-mediated Pulmonary Fibrosis is IL-17A Dependent

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2010 Feb 24

PMID 20176803

Citations 382

Authors

Mark S Wilson

Satish K Madala

Thirumalai R Ramalingam

Bernadette R Gochuico

Ivan O Rosas

Allen W Cheever

Thomas A Wynn

Affiliations

Soon will be listed here.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4(+) and gammadelta(+) T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a(-/-) mice confirmed an essential role for IL-17A. Mechanistically, using ifngamma(-/-), il10(-/-), il10(-/-)il12p40(-/-), and il10(-/-)il17a(-/-) mice and TGF-beta blockade, we demonstrate that IL-17A-driven fibrosis is suppressed by IL-10 and facilitated by IFN-gamma and IL-12/23p40. BLM-induced IL-17A production was also TGF-beta dependent, and recombinant IL-17A-mediated fibrosis required TGF-beta, suggesting cooperative roles for IL-17A and TGF-beta in the development of fibrosis. Finally, we show that fibrosis induced by IL-1beta, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1beta were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.

Citing Articles

Emergence of inflammatory fibroblasts with aging in Hermansky-Pudlak syndrome associated pulmonary fibrosis.

Banaschewski B, Michki S, Sitaraman S, Pan R, Wang J, Stewart D Commun Biol. 2025; 8(1):284.

PMID: 39987372 PMC: 11846979. DOI: 10.1038/s42003-025-07589-9.

The role of interleukin-17 in inflammation-related cancers.

Zhang X, Li B, Lan T, Chiari C, Ye X, Wang K Front Immunol. 2025; 15:1479505.

PMID: 39906741 PMC: 11790576. DOI: 10.3389/fimmu.2024.1479505.

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis.

Gangi S, Bergantini L, Paggi I, Spalletti M, Cameli P, Bargagli E Immun Inflamm Dis. 2025; 13(1):e70123.

PMID: 39807767 PMC: 11729443. DOI: 10.1002/iid3.70123.

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.

Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into pathogenesis.

Shadid A, Rich H, DeVaughn H, Domozhirov A, Doursout M, Weng-Mills T Front Cell Infect Microbiol. 2025; 14:1479801.

PMID: 39760094 PMC: 11695292. DOI: 10.3389/fcimb.2024.1479801.

References

Everts B, Perona-Wright G, Smits H, Hokke C, van der Ham A, Fitzsimmons C . Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med. 2009; 206(8):1673-80. PMC: 2722183. DOI: 10.1084/jem.20082460. View

Cutroneo K, White S, Phan S, Ehrlich H . Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol. 2007; 211(3):585-9. DOI: 10.1002/jcp.20972. View

Laan M, Cui Z, Hoshino H, Lotvall J, Sjostrand M, Gruenert D . Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999; 162(4):2347-52. View

Kradin R, Sakamoto H, Jain F, Zhao L, Hymowitz G, Preffer F . IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Exp Mol Pathol. 2004; 76(3):205-11. DOI: 10.1016/j.yexmp.2003.12.010. View

Manoury B, Caulet-Maugendre S, Guenon I, Lagente V, Boichot E . TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Int J Immunopathol Pharmacol. 2006; 19(3):471-87. DOI: 10.1177/039463200601900303. View

Anderson C, Oukka M, Kuchroo V, Sacks D . CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med. 2007; 204(2):285-97. PMC: 2118728. DOI: 10.1084/jem.20061886. View

Hoshino T, Okamoto M, Sakazaki Y, Kato S, Young H, Aizawa H . Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. Am J Respir Cell Mol Biol. 2009; 41(6):661-70. PMC: 10283344. DOI: 10.1165/rcmb.2008-0182OC. View

Bettelli E, Korn T, Oukka M, Kuchroo V . Induction and effector functions of T(H)17 cells. Nature. 2008; 453(7198):1051-7. PMC: 6280661. DOI: 10.1038/nature07036. View

Czaja M, Weiner F, Flanders K, Giambrone M, Wind R, BIEMPICA L . In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol. 1989; 108(6):2477-82. PMC: 2115595. DOI: 10.1083/jcb.108.6.2477. View

10.

Kaviratne M, Hesse M, Leusink M, Cheever A, Davies S, McKerrow J . IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol. 2004; 173(6):4020-9. DOI: 10.4049/jimmunol.173.6.4020. View

11.

Ramalingam T, Pesce J, Sheikh F, Cheever A, Mentink-Kane M, Wilson M . Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol. 2007; 9(1):25-33. PMC: 2692551. DOI: 10.1038/ni1544. View

12.

Ma H, Liang S, Li J, Napierata L, Brown T, Benoit S . IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 2008; 118(2):597-607. PMC: 2200300. DOI: 10.1172/JCI33263. View

13.

Hunninghake G, Gadek J, Lawley T, Crystal R . Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1981; 68(1):259-69. PMC: 370793. DOI: 10.1172/jci110242. View

14.

Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Wisniewska J, Polubinska A . IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol. 2000; 165(10):5814-21. DOI: 10.4049/jimmunol.165.10.5814. View

15.

Jakubzick C, Choi E, Joshi B, Keane M, Kunkel S, Puri R . Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol. 2003; 171(5):2684-93. DOI: 10.4049/jimmunol.171.5.2684. View

16.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

17.

Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, Zieske A . IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998; 161(11):6383-9. View

18.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

19.

Laan M, Lotvall J, Chung K, Linden A . IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001; 133(1):200-6. PMC: 1572774. DOI: 10.1038/sj.bjp.0704063. View

20.

Wang R, Verlinski L, Pick R, Uhal B . Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2000; 279(1):L143-51. DOI: 10.1152/ajplung.2000.279.1.L143. View